The U.S. recently backed out of the United Nation's HIV/AIDS program and froze billions in foreign HIV-prevention efforts.

The House of Representatives narrowly passed a budget resolution, which Malliotakis voted in favor of, late last month.

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

There were empty seats in San Francisco last week at an annual international science conference that has delivered some of the world's most groundbreaking HIV research. It was a throwback to another ...

In his Tuesday address to Congress, President Trump listed U.S.-funded programs that he considers an "appalling waste" — ...

The national health department has tried to reassure the public that the country’s HIV response is mostly funded by the ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

While TB treatment takes six long months, this is a curable disease. HIV, on the other hand, cannot be cured. It can, however, be kept in check through medicine that suppresses the infection.